Syndax Pharmaceuticals
Clinical trials sponsored by Syndax Pharmaceuticals, explained in plain language.
-
Last-Chance treatment offered for tough leukemia cases
Disease control NO_LONGER_AVAILABLEThis program provided access to an experimental drug called SNDX-5613 for patients with relapsed or refractory acute leukemia who had no other treatment options. It was designed for people who couldn't join other clinical trials and had specific genetic changes in their leukemia …
Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope for transplant patients battling debilitating chronic GVHD
Disease control OngoingThis study is testing a drug called axatilimab for people with chronic graft-versus-host disease (cGVHD) that has come back or hasn't improved after trying at least two other treatments. The goal is to see if the drug can reduce the disease's severity and symptoms, and to find th…
Phase: PHASE2 • Sponsor: Syndax Pharmaceuticals • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC